These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6282932

  • 1. Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.
    Fujimoto T, Ohara S, Hawiger J.
    J Clin Invest; 1982 Jun; 69(6):1212-22. PubMed ID: 6282932
    [Abstract] [Full Text] [Related]

  • 2. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ, Pizzo SV, McKee PA.
    J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
    [Abstract] [Full Text] [Related]

  • 3. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding.
    Peerschke EI.
    Blood; 1992 Feb 15; 79(4):948-53. PubMed ID: 1737104
    [Abstract] [Full Text] [Related]

  • 4. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S, Kloczewiak M, Hawiger J.
    Proc Natl Acad Sci U S A; 1984 Aug 15; 81(15):4935-9. PubMed ID: 6087354
    [Abstract] [Full Text] [Related]

  • 5. Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin.
    van Willigen G, Akkerman JW.
    Blood; 1992 Jan 01; 79(1):82-90. PubMed ID: 1309427
    [Abstract] [Full Text] [Related]

  • 6. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL, Kupinski JM, Castella A, Ruggeri ZM.
    J Clin Invest; 1983 Nov 01; 72(5):1532-42. PubMed ID: 6415113
    [Abstract] [Full Text] [Related]

  • 7. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J, Parkinson S, Timmons S.
    Nature; 1980 Jan 10; 283(5743):195-7. PubMed ID: 6985716
    [Abstract] [Full Text] [Related]

  • 8. Platelets have more than one binding site for von Willebrand factor.
    Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR.
    J Clin Invest; 1983 Jul 10; 72(1):1-12. PubMed ID: 6223940
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
    Schneider-Trip MD, Jenkins CS, Kahlé LH, Sturk A, ten Cate JW.
    Br J Haematol; 1979 Sep 10; 43(1):99-112. PubMed ID: 508625
    [Abstract] [Full Text] [Related]

  • 10. Platelet-binding of the von Willebrand factor.
    Green D, Muller HP.
    Thromb Haemost; 1978 Jun 30; 39(3):689-94. PubMed ID: 309191
    [Abstract] [Full Text] [Related]

  • 11. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets.
    Graber SE, Hawiger J.
    J Biol Chem; 1982 Dec 25; 257(24):14606-9. PubMed ID: 6294072
    [Abstract] [Full Text] [Related]

  • 12. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS, Peerschke EI, Seligsohn U, Scudder LE, Nurden AT, Rosa JP.
    J Lab Clin Med; 1986 Apr 25; 107(4):384-92. PubMed ID: 2420911
    [Abstract] [Full Text] [Related]

  • 13. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J, Jordan J, Montgomery RR.
    J Clin Invest; 1984 Feb 25; 73(2):421-8. PubMed ID: 6230372
    [Abstract] [Full Text] [Related]

  • 14. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.
    Cooper HA, Bennett WP, White GC, Wagner RH.
    Proc Natl Acad Sci U S A; 1982 Mar 25; 79(5):1433-7. PubMed ID: 7041120
    [Abstract] [Full Text] [Related]

  • 15. Phospholipase abolishes the effect of stimulated platelets on the thrombin activation of factor VIII.
    Rick ME, Krizek DM.
    Blood; 1988 Jan 25; 71(1):173-7. PubMed ID: 3120821
    [Abstract] [Full Text] [Related]

  • 16. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT, Hodson E, Roberts JR, Kunicki TJ, Zimmerman TS, Ruggeri ZM.
    J Clin Invest; 1985 Nov 25; 76(5):1950-8. PubMed ID: 2414325
    [Abstract] [Full Text] [Related]

  • 17. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets.
    Hultin MB.
    Blood; 1985 Jul 25; 66(1):53-8. PubMed ID: 3924141
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing the deaggregation of human and rabbit platelets.
    Kinlough-Rathbone RL, Mustard JF, Perry DW, Dejana E, Cazenave JP, Packham MA, Harfenist EJ.
    Thromb Haemost; 1983 Jun 28; 49(3):162-7. PubMed ID: 6308846
    [Abstract] [Full Text] [Related]

  • 19. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS, Phillips DR, Clemetson KJ, Meyer D, Larrieu MJ, Lüscher EF.
    J Clin Invest; 1976 Jan 28; 57(1):112-24. PubMed ID: 1081991
    [Abstract] [Full Text] [Related]

  • 20. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
    Darius H, Binz C, Veit K, Fisch A, Meyer J.
    J Am Coll Cardiol; 1995 Sep 28; 26(3):800-6. PubMed ID: 7543911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.